Jupiter Life Line Hospitals Ltd - Stock Valuation and Financial Performance

BSE: 543980 | NSE: JLHL | Hospital & Healthcare Services | Small Cap

Jupiter Life Line Share Price

1,344 -19.20 -1.41%
as on 31-Oct'24 16:01

DeciZen - make an informed investing decision on Jupiter Life Line

Overall Rating
Bole Toh

1. Quality

2. Valuation

Somewhat overvalued

3. Price Trend

Semi Strong

Jupiter Life Line Hospitals stock performance -

mw4me loader
P/E Ratio (SA):
54.46
Market Cap:
8,832.1 Cr.
52-wk low:
977.5
52-wk high:
1,648.6

Is Jupiter Life Line Hospitals Ltd an attractive stock to invest in?

1. Is Jupiter Life Line Hospitals Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Jupiter Life Line Hospitals Ltd is a good quality company.

2. Is Jupiter Life Line Hospitals Ltd undervalued or overvalued?

The key valuation ratios of Jupiter Life Line Hospitals Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Jupiter Life Line Hospitals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Jupiter Life Line Hospitals Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Jupiter Life Line:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Jupiter Life Line Hospitals Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 30.7%23.9%17.2%10.4%10%12.1%9%23.2%26.4%22.2%-
Value Creation
Index
1.30.80.3-0.2-0.3-0.1-0.30.71.00.6-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 222251264320399463461657787911942
Sales YoY Gr.-13%5.4%21.3%24.4%16.2%-0.4%42.6%19.8%15.7%-
Adj EPS 6.56.25.85.93.65.83.316.619.223.224.7
YoY Gr.--4.9%-6.8%1.6%-39.5%63.5%-44%409.2%15.7%20.7%-
BVPS (₹) 22.827.933.73941.946.549.864.382.3189.9196.1
Adj Net
Profit
32.731.129.329.918.129.616.684.5109152162
Cash Flow from Ops. 45.949.962.743.545.674.6113142184110-
Debt/CF from Ops. 1.82.334.85.53.52.32.31.60-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 17%18%25.5%15.7%
Adj EPS 15.1%45.5%92.3%20.7%
BVPS26.6%35.3%56.2%130.8%
Share Price - - - 36.2%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
35.925.318.916.28.813.26.82927.417.812.8
Op. Profit
Mgn %
27.324.423.31716.317.614.624.225.924.524.2
Net Profit
Mgn %
14.712.411.19.34.56.43.612.913.816.717.2
Debt to
Equity
0.80.81.11.11.21.1110.60-
Working Cap
Days
53535054658891546211678
Cash Conv.
Cycle
-52-37-42-41-28-29-36-35-32-2358

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 25.46%

Net Profit is growing at healthy rate in last 3 years 92.29%

Sales growth is good in last 4 quarters at 15.41%

Return on Equity has declined versus last 3 years average to 12.80%

Latest Financials - Jupiter Life Line Hospitals Ltd.

Standalone Consolidated
TTM EPS (₹) 24.7 25.5
TTM Sales (₹ Cr.) 942 1,113
BVPS (₹.) 196.1 185.1
Reserves (₹ Cr.) 1,220 1,148
P/BV 6.87 7.28
PE 54.46 52.82
From the Market
52 Week Low / High (₹) 977.45 / 1648.60
All Time Low / High (₹) 960.00 / 1648.60
Market Cap (₹ Cr.) 8,832
Equity (₹ Cr.) 65.6
Face Value (₹) 10
Industry PE 41.2

Management X-Ray of Jupiter Life Line:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Jupiter Life Line

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales222251264320399463461657787911
Operating Expenses 161189203266334382394498583687
Manufacturing Costs12151723516156678995
Material Costs44495060818094127135159
Employee Cost 313743678293100114129153
Other Costs 748893116120148143190230281
Operating Profit 61616254658168159204223
Operating Profit Margin (%) 27.3%24.4%23.3%17.0%16.3%17.6%14.6%24.2%25.9%24.5%
Other Income 223533641330
Interest 108816242628292819
Depreciation 10111220242627282931
Exceptional Items 00000000-20
Profit Before Tax 43454524203318106159204
Tax 101415-6231215252
Profit After Tax 3331293018301785107152
PAT Margin (%) 14.7%12.4%11.1%9.3%4.6%6.4%3.6%12.9%13.6%16.7%
Adjusted EPS (₹)7.06.25.85.93.65.83.316.719.023.2
Dividend Payout Ratio (%)7%8%9%9%28%0%0%6%5%4%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 1061401701982132372533274651,245
Share Capital 47505151515151515766
Reserves 60901201471621862022764091,180
Minority Interest0000000000
Debt751041801972412542503192950
Long Term Debt54881771862342442582982950
Short Term Debt2016311710-92100
Trade Payables20182837375950546251
Others Liabilities 30374138454463556365
Total Liabilities 2312984204705375946157558851,361

Fixed Assets

Gross Block202224319471547576595660700731
Accumulated Depreciation50617393116141168195224254
Net Fixed Assets151163246379431435426465476477
CWIP 379213228121113141661
Investments 111122657195111
Inventories56610101412131517
Trade Receivables12121318264520284046
Cash Equivalents 46348719102133297
Others Assets2118173148815962108351
Total Assets 2312984204705375946157558851,361

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 465063434675113142184110
PBT 43454524203318106159204
Adjustment 19191831456654544926
Changes in Working Capital -7-29-0-5-951-910-71
Tax Paid -6-8-9-11-14-15-10-9-33-50
Cash Flow From Investing Activity -34-76-133-43-58-43-78-69-130-256
Capex -35-77-135-48-60-29-22-66-43-76
Net Investments 000010-57-5-34-15
Others 11251-1512-52-165
Cash Flow From Financing Activity -92868116-32-2310-23311
Net Proceeds from Shares 0521000234633
Net Proceeds from Borrowing 00004771831-3-295
Interest Paid -10-8-8-16-24-26-28-29-28-19
Dividend Paid -284-3-3-3-500-5-6
Others 3-537718-4-9-137-21-3
Net Cash Flow 32-313-1128431164
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)35.8625.318.8916.238.8213.176.7729.1827.0717.77
ROCE (%)30.7423.9417.1910.429.9512.149.0123.1526.422.16
Asset Turnover Ratio1.040.950.740.720.790.820.760.960.960.81
PAT to CFO Conversion(x)1.391.612.171.432.562.56.651.671.720.72
Working Capital Days
Receivable Days16171718202826131617
Inventory Days888991010776
Payable Days170141167196167219210149157130

Jupiter Life Line Hospitals Ltd Stock News

Jupiter Life Line Hospitals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Jupiter Life Line on 31-Oct-2024 16:01 is ₹1,344.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Oct-2024 16:01 the market cap of Jupiter Life Line stood at ₹8,832.1.
The latest P/E ratio of Jupiter Life Line as of 31-Oct-2024 16:01 is 54.46.
The latest P/B ratio of Jupiter Life Line as of 31-Oct-2024 16:01 is 6.87.
The 52-week high of Jupiter Life Line is ₹1,648.6 and the 52-week low is ₹977.5.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Jupiter Life Line is ₹942.2 ( Cr.) .

About Jupiter Life Line Hospitals Ltd

Jupiter Life Line Hospitals was incorporated in Mumbai, Maharashtra, as ‘Jupiter Life Line Hospitals Limited’, a public limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated November 18, 2002, issued by the RoC. The company commenced its business on December 24, 2002. The company is among the key multi-specialty tertiary and quaternary healthcare providers in the Mumbai Metropolitan Area (MMR) and western region of India. It has been operating for many years as a corporate quaternary care healthcare service provider in densely populated micro markets in the western regions of India and currently operate three hospitals under the ‘Jupiter’ brand in Thane, Pune and Indore. It is also currently in the process of developing a multi-specialty hospital in Dombivli, Maharashtra, which is designed to accommodate many beds.

The company commenced operations in 2007 with its hospital in Thane, Maharashtra and subsequently scaled its operations by setting up a hospital in Pune, Maharashtra in 2017 and acquiring a hospital in Indore, Madhya Pradesh in 2020. Its hospitals are also located in densely populated micro markets which have a low presence of chained hospitals, which provides it an opportunity to offer its services to a larger population and helps its patients with greater access and connectivity to healthcare services. Its hospitals function on an ‘all-hub-no-spoke’ model with each hospital being a full-service hospital, operating independently and serving the healthcare needs of patients, right from diagnostics to surgery and rehabilitation. Its Thane and Pune hospitals are ‘greenfield’ projects, and all three of its hospitals are located on land owned by it on a freehold basis, which ensures operational control and allows it consistency in quality care resulting in long-term operational and financial efficiencies.

Business area of the company

The company is engaged in the business of operating and managing hospitals and clinics in India. The company is among the key multi-specialty tertiary and quaternary healthcare providers.

Awards

  • 2018: Awarded the Best Multispecialty hospital in Thane District at the NavBharat Healthcare Excellence Awards.
  • 2019: Awarded the Hospital of the year - India at the Healthcare Asia Awards.
  • 2019: Awarded for outstanding contribution in charitable healthcare at the Star of the Industry Awards.
  • 2019: Received the award for best design in healthcare for its Indore Hospital, at the Healthcare Leadership Awards.
  • 2021: Recognized for excellence in change management for its Thane Hospital at the CHRO Vision & Innovation Summit and Awards.
  • 2021: Winner of the award for excellence in workplace management for the human resources department of its Thane Hospital at the CHRO Vision & Innovation Summit and Awards.
  • 2021: Received the Silver award - Covid Protection Project at the IHW Awards.
  • 2022: Received the NEERMAN award in the healthcare category for its Pune Hospital.
  • 2022: Received the milestone merits 2022 - safety award from the IMC Ramkrishna Bajaj National Quality Trust.
  • 2023: Awarded the certificate of excellence for its Indore Hospital for being the cleanest hospital in Indore at the Swachh Ward Rankings.
  • 2023: Awarded the Maharashtra state best employer brand award, 2023 at the 18th Employer Branding Awards.

Accreditations and recognitions

  • 2020: Accreditation for its Thane Hospital by the National Accreditation Board for Hospital & Healthcare Providers.
  • 2020: Accreditation for its Pune Hospital, Maharashtra by the National Accreditation Board for Hospital & Healthcare Providers.
  • 2021: Accreditation for its Indore Hospital, Madhya Pradesh by the National Accreditation Board for Hospital & Healthcare Providers.
  • 2022: ISO 15189:2012 accreditation for the department of laboratory medicine of its Pune Hospital by the National Accreditation Board for Testing and Calibration Laboratories.
  • 2022: ISO 15189:2012 accreditation for the department of laboratory medicine of its Thane Hospital by the National Accreditation Board for Testing and Calibration Laboratories.
  • 2023: ISO 22000:2018 accreditation for food safety and management system for the Fortune Park Lake City hotel at Thane by the Standards Council of Canada.

History and milestones

  • 2007: Established and commenced operations of its first hospital at Thane, Maharashtra.
  • 2017: Established and commenced operations of its Pune Hospital.
  • 2018: Carried out interstitial brachytherapy to treat cancer at its Thane Hospital.
  • 2020: Acquired its Indore Hospital.
  • 2021: Successfully carried out small bowel intestine transplant surgery at its Thane, Hospital.
  • 2022: Successfully carried out heart transplant surgery at its Thane Hospital.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.